Regional CNS responses to IFN-γ determine lesion localization patterns during EAE pathogenesis
Open Access
- 13 October 2008
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 205 (11), 2633-2642
- https://doi.org/10.1084/jem.20080155
Abstract
The localization of inflammatory foci within the cerebellum is correlated to severe clinical outcomes in multiple sclerosis (MS). Previous studies of experimental autoimmune encephalomyelitis (EAE), a model of MS, revealed distinct clinical outcomes correlated with the capacity of the animal to produce IFN-gamma. Outcomes were linked to localization of inflammatory cells in either the spinal cord (wild type [WT]) or the cerebellum and brain stem (IFN-gamma deficient). We demonstrate, using an adoptive transfer system, that the ability of the central nervous system (CNS) to sense pathogenic T cell-produced IFN-gamma during EAE initiation determines the sites of CNS pathogenesis. Transfer of WT Th1 cells into IFN-gamma receptor-deficient mice results in pathogenic invasion of the brain stem and cerebellum with attendant clinical symptoms, which are identical to the disease observed after transfer of IFN-gamma-deficient T cells to WT hosts. Inflammation of the spinal cord associated with classical EAE is abrogated in both IFN-gamma-deficient systems. Cotransfer of CNS antigen-specific WT Th1 cells with IFN-gamma-deficient T cells is sufficient to restore spinal cord invasion and block cerebellar and brain stem invasion. These data demonstrate that interaction between IFN-gamma and host CNS cells during the initiation of EAE can selectively promote or suppress neuroinflammation and pathogenesis.Keywords
This publication has 53 references indexed in Scilit:
- Early prognostic factors for disability in multiple sclerosis, a European multicenter studyActa Neurologica Scandinavica, 2009
- Differential regulation of central nervous system autoimmunity by TH1 and TH17 cellsNature Medicine, 2008
- Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitisEuropean Journal of Immunology, 2006
- Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell TiesImmunity, 2006
- The IL-23/IL-17 axis in inflammationJournal of Clinical Investigation, 2006
- Transforming growth factor-β induces development of the TH17 lineageNature, 2006
- Modulation of Immunity-Related Gene Expression in Small Intestines of Mice by Oral Administration of LactoferrinClinical and Vaccine Immunology, 2006
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcomeMultiple Sclerosis Journal, 1999
- Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patientsCellular Immunology, 1990